Co-founder Carel Hoyng honoured with Dutch Medical Retina Award
15 November 2024
Today, our co-founder, Prof. dr. Carel Hoyng, will be giving a special talk at the…
Leadership transition that continues driving our mission
1 October 2024
Our CEO, Berno Maaswinkel, will be stepping down as he faces personal circumstances that make…
CSO Rob Collin opens 5th Gene Therapy Summit in Boston
9 September 2024
On Wednesday, September 11, Astherna’s Chief Scientific Officer, Prof. Rob Collin, will open Day 1…
Our CSO keynotes at Dutch Antisense Therapeutics Symposium
22 May 2024
Our Chief Scientific Officer, Prof. dr. Rob Collin, will be a keynote speaker at the…
Astherna’s co-founder awarded €22M grant for Lifelong Vision
5 April 2024
Astherna celebrates the achievement of one of our co-founders, Prof. Rob Collin, a key member…
BIO-Europe Spring and the start of Series A funding round
22 March 2024
This week, our CEO represented us at BIO-Europe Spring in Barcelona, a key moment as…